Trasylol (aprotinin injection) Overview
February 15, 2006Trasylol is manyfactured by Bayer Pharmaceuticals and is designed for patients who undergo Cardiopulmonary Bypass (CPB) for Coronary Artery Bypass Graft (CABG) surgery. Trasylol has been linked to adverse events including stroke, encephalopathy, heart attack and kidney damage, and studies have shown that there are cheaper and safer generic options options available.
more...